JAMP-RISPERIDONE: may contain foreign matter particles
Brand(s)
Last updated
Summary
Product
JAMP-RISPERIDONE
Issue
Health products - Product safety
What to do
Consult your healthcare provider prior to discontinuing use of the affected product, or for any health concerns.
Affected products
Brand |
Product Name |
Market Authorization |
Dosage Form |
Strength |
Lot |
|---|---|---|---|---|---|
JAMP-RISPERIDONE |
JAMP-RISPERIDONE |
DIN 02359529 |
Tablet |
Risperidone 0.25 mg |
ENN064001 |
Issue
The affected batch may contain foreign matter particles.
What you should do
- Verify if your product is affected.
- Consult your healthcare provider prior to discontinuing use of the affected product(s), or for any health concerns.
- Contact the recalling firm if you have any questions about the recall.
- Report any health product related side effects to Health Canada.
- Report any other health product safety complaints to Health Canada.
Additional information
Background
Depth of recall: Wholesalers
Details
Original published date:
Alert / recall type
Health product recall
Category
Health products - Drugs
Companies
JAMP PHARMA CORPORATION.
1310 rue Nobel,
Boucherville, QC,
J4B 5H3
Published by
Health Canada
Audience
General public
Healthcare
Industry
Recall class
Type III
Identification number
RA-77516
Get notified
Receive notifications for new and updated recalls and alerts by category.